Downregulation of angiotensin converting enzyme II is associated with pacing‐induced sustained atrial fibrillation

[1]  Yang Miao,et al.  Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[2]  M. Hirai,et al.  Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[3]  N. Mochizuki,et al.  Angiotensin II Type 1 Receptor Blocker Prevents Atrial Structural Remodeling in Rats with Hypertension Induced by Chronic Nitric Oxide Inhibition , 2006, Hypertension Research.

[4]  M. Huentelman,et al.  Protection from angiotensin II‐induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats , 2005, Experimental physiology.

[5]  C. Hsu,et al.  Differentially transcribed genes in skeletal muscle of Duroc and Taoyuan pigs. , 2005, Journal of animal science.

[6]  W. Linz,et al.  Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril , 1989, Cardiovascular Drugs and Therapy.

[7]  Jian Peng,et al.  Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers , 2004, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[8]  Sander Verheule,et al.  Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.

[9]  D. Averill,et al.  Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors , 2004, Hypertension.

[10]  Yung-Zu Tseng,et al.  Functional Genomic Study on Atrial Fibrillation Using cDNA Microarray and Two‐Dimensional Protein Electrophoresis Techniques and Identification of the Myosin Regulatory Light Chain Isoform Reprogramming in Atrial Fibrillation , 2004, Journal of cardiovascular electrophysiology.

[11]  Tangchun Wu,et al.  Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[12]  K. Arakawa,et al.  Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[13]  A. Ducharme,et al.  Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials , 2003, Circulation.

[14]  C. Lin,et al.  Structural and biochemical evidence of mitochondrial depletion in pigs with hypertrophic cardiomyopathy. , 2003, Research in veterinary science.

[15]  L. Lai,et al.  Electrophysiological Mapping and Histological Examinations of the Swine Atrium with Sustained (≥24 h) Atrial Fibrillation: A Suitable Animal Model for Studying Human Atrial Fibrillation , 2003, Cardiology.

[16]  K. Arakawa,et al.  Reperfusion-Induced Arrhythmias Are Suppressed by Inhibition of the Angiotensin II Type 1 Receptor , 2003, Cardiology.

[17]  E. Saunders,et al.  Blockade of the Renin‐Angiotensin System in African Americans With Hypertension and Cardiovascular Disease , 2003, Journal of clinical hypertension.

[18]  M. Crackower,et al.  Angiotensin-converting enzyme 2 is an essential regulator of heart function , 2002, Nature.

[19]  A. Goette,et al.  Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. , 2002, Cardiovascular research.

[20]  S. Nattel,et al.  Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. , 2002, Cardiovascular research.

[21]  S. Nattel.  New ideas about atrial fibrillation 50 years on , 2002, Nature.

[22]  S. Nattel,et al.  Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure , 2001, Circulation.

[23]  C. Johnston,et al.  Angiotensin receptors: distribution, signalling and function. , 2001, Clinical science.

[24]  M. Clark,et al.  Angiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells , 2001, Hypertension.

[25]  H. Heitsch,et al.  Angiotensin-(1-7)–Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells , 2001, Hypertension.

[26]  Nigel M. Hooper,et al.  A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.

[27]  C. Chatziantoniou,et al.  Angiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway , 2000, Hypertension.

[28]  K. Robison,et al.  A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 , 2000, Circulation research.

[29]  G. Breithardt,et al.  Maintenance of sinus rhythm as a therapy goal. , 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  J. Sadoshima.  Cytokine actions of angiotensin II. , 2000, Circulation research.

[31]  A. Goette,et al.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. , 2000, Circulation.

[32]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[33]  L. Køber,et al.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. , 1999, Circulation.

[34]  S Nattel,et al.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[35]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.

[36]  D. Webb,et al.  Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. , 1998, Circulation.

[37]  H. Matsubara,et al.  Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. , 1998, Circulation research.

[38]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[39]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[40]  A. Clerk,et al.  Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. , 1997, Cellular signalling.

[41]  K. Arakawa,et al.  Effects of an Angiotensin II Antagonist on Reperfusion Arrhythmias in Dogs , 1997, Pacing and clinical electrophysiology : PACE.

[42]  T. Unger,et al.  The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells , 1996, Molecular and Cellular Endocrinology.

[43]  N. Iwai,et al.  Cardiac renin-angiotensin system in the hypertrophied heart. , 1995, Circulation.

[44]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[45]  Y. Zou,et al.  Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. , 1995, The Journal of clinical investigation.

[46]  J. Cohn.  Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. , 1995, Circulation.

[47]  Douglas L. Jones,et al.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.

[48]  J. Gardin,et al.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[49]  K. Weber,et al.  Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. , 1994, Journal of molecular and cellular cardiology.

[50]  H. Drexler,et al.  Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. , 1994, The Journal of clinical investigation.

[51]  H. Drexler,et al.  Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. , 1994, Circulation.

[52]  C. Heusser,et al.  Characterization of a monoclonal antibody specific for human active renin. , 1992, Hypertension.

[53]  C. Ferrario.  Biological Roles of Angiotensin-(1-7). , 1992 .

[54]  B. Healy,et al.  Angiotensin II-forming pathways in normal and failing human hearts. , 1990, Circulation research.

[55]  T. Sturgill,et al.  Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D W Cushman,et al.  Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. , 1971, Biochemical pharmacology.

[57]  W. Evans,et al.  LONE AURICULAR FIBRILLATION , 1954, British heart journal.

[58]  H W Allen,et al.  Auricular Fibrillation. , 1913, California state journal of medicine.